Optimal treatment of ceftazidime-avibactam and aztreonam-avibactam against bloodstream infections or lower respiratory tract infections caused by extensively drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa - Kang, Yixin; Xie, Lu; Yang, Jiyong; Cui, Junchang (Frontiers in cellular and infection microbiology, 2023)
Keywords: 173 aztreonam-avibactam; Anti-Bacterial Agents - pharmacology; Anti-Bacterial Agents - therapeutic use; Aztreonam - pharmacology; beta-Lactamases; ceftazidime-avibactam; Cellular and Infection Microbiology; Drug Combinations; extensively drug-resistant Pseudomonas aeruginosa; Humans; Microbial Sensitivity Tests; pan drug-resistant Pseudomonas aeruginosa; Pharmaceutical Preparations; Pseudomonas aeruginosa; Pseudomonas Infections - drug therapy; Respiratory Tract Infections - drug therapy; Sepsis - drug therapy; whole-genome sequencing; extensively drug-resistant Pseudomonas aeruginosa; ceftazidime-avibactam; pan drug-resistant Pseudomonas aeruginosa; whole-genome sequencing; 173 aztreonam-avibactam